Latest News & Blog
Keep up to date with the latest British Liver Trust news and blogs, including our campaigns, fundraising activities, research, health information and achievements, as well as the latest news on liver disease or cancer treatment, care and support.
If you are a journalist and need to contact us, please call 01425 481 320 or email media@britishlivertrust.org.uk.
England is poised to eliminate hepatitis C if those still undiagnosed can be found
A government debate on the elimination of Hepatitis C took place in Parliament today (12 June). The …
Shift from budget to mid-market alcohol in Scotland
The Institute of Alcohol Studies have advised that Scottish wholesalers have reported shifts from budget alcohol to …
How you can support Love Your Liver week
From 18th to 24th June 2018, it is Love Your Liver week, which takes place every year …
Early research into new blood test to detect liver damage in under an hour
A quick and robust blood test that can detect liver damage before symptoms appear has been …
‘Blueprint to beat cancer’ launched today
Worldwide research review project underpins latest, evidence-based Cancer Prevention Recommendations Lifestyles featuring little exercise and lots …
British Liver Trust lends support to first International NASH Day
The British Liver Trust is supporting the first ever global day of action against fatty liver diseases. …
Trust writes to Home Secretary
The Trust has joined forces with other leading health charities to urge the Rt Hon Sajid Javid …
All-Party Parliamentary Group on Obesity launches its inquiry findings
The All-Party Parliamentary Group on Obesity launched its inquiry findings today at an official event in Parliament. The …
More than 1 in 10 visitors to liver health roadshow required follow-up tests for Liver Disease
Hundreds of people received advice and tests for liver disease when the Love Your Liver campaign, a …
British Liver Trust welcomes SMCs decision to approve regorafenib for liver cancer patients
The Scottish Medicines Consortium (SMC) has accepted Stivarga® (regorafenib) for use as a monotherapy for the treatment …